google ads

Balancing Diagnostic Efficacy and Radiation Modulation for MDCT Imaging of Renal Cell Carcinoma

Balancing Diagnostic Efficacy and Radiation Modulation for MDCT Imaging of Renal Cell Carcinoma

Elliot K Fishman, MD, FACR

The Russell H. Morgan Department of Radiology and Radiological Science
The Johns Hopkins Medical Institutions
Baltimore, MD

 

Multiphase & MPR for Detection

Subtle hypervascular lesion within the posterior right kidney, which is isoattenuating on venous phase and only apparent on the arterial images. The lesion is subtle on the axial image but is more apparent on coronal MPR. Inspection of kidneys with coronal MPRs is critical component of search patterns to ensure diagnostic efficacy.

Multiphase & MPR for Detection

 

Clear Cell RCC Case

Classic imaging features in 71 year old female with pathologically proven clear cell RCC (arrow) of the right kidney. Heterogeneous avidly enhancing lesion that is highest attenuation on arterial phase and progressively washes out measuring 160 HU on corticomedullary phase, 155 HU on nephrographic phase, and 86 HU on delayed phase.

Clear Cell RCC Case

 

Papillary RCC Case

Homogeneous mildly enhancing lesion within the right kidney reaching 49 HU on corticomedullary phase and 66 HU on venous and delayed phases resected and found to be a papillary RCC. Progressive enhancement as seen in this case characteristic of papillary lesions and not a feature of clear cell lesions.

Papillary RCC Case

 

CT Findings Aiding in Surgical Planning

79 year old woman with newly diagnosed highly vascular clear cell carcinoma in the right kidney. Multiphase imaging enables reliable distinction of clear cell from papillary and chromophobe variants by demonstrating CM phase hypervascularity and progressive washout on nephrographic and delayed phases. Large feeding arteries (circle), demonstrated by arterial phase MIP rendering, may result in conversion from a laparoscopic to an open procedure and are important to report to the urologist.

CT Findings Aiding in Surgical Planning

 

Partial Nephrectomy: Surgical Material vs Tumor

Noncontrast images are essential in the postoperative patient to distinguish surgical material from enhancing tumor recurrence. These images demonstrate surgical material (arrow) at the nephrectomy site that mimics enhancement on postcontrast images.

Partial Nephrectomy:Surgical Material vs Tumor

 

Partial Nephrectomy: Surgical Material vs Tumor

Status post partial nephrectomy with a focus of enhancement (arrow) on corticomedullary phase representing local recurrence. Noncontrast images enable the distinction between surgical material and enhancing lesion. The recurrent lesion is isodense on venous and delayed phase, underscoring the importance of the arterial acquisition .

Partial Nephrectomy:Surgical Material vs Tumor

 

Pancreatic and Contralateral Kidney Metastases

Patient with left clear cell RCC status post nephrectomy, metastases to the contralateral kidney (arrows) and pancreatic tail (circle). The lesions avidly enhance on arterial phase. The renal lesion is nearly isodense on each of the additional phases while the pancreatic lesion remains mildly hyperdense relative to parenchyma on the venous phase. Noncontrast is noncontributory.

Pancreatic and Contralateral Kidney Metastases

 

Clear Cell RCC Metastasis

Two different patients are shown. On the left (A,B), arterial and delayed phase images in a patient with clear cell RCC show an arterial phase avidly enhancing metastatic lesion in the left seminal vesicle (circle),which would have been missed on the delayed phase. On the right (C,D), patient with clear cell status post left nephrectomy has a right paraspinal enhancing metastatic lesion (arrow) more conspicuous on arterial phase.

Clear Cell RCC Metastasis

 

Pancreatic Uncinate Metastasis

Status post right nephrectomy for clear cell RCC with avidly enhancing metastasis (circle) in the pancreatic uncinate only discernible on arterial phase. The lesion becomes isodense to pancreatic parenchyma on venous phase, again demonstrating the diagnostic importance of arterial phase imaging in RCC surveillance.

Pancreatic Uncinate Metastasis

 

Hepatic Metastasis

Patient with clear cell RCC status post partial left nephrectomy with avidly enhancing metastatic liver lesions (circles) seen only on arterial phase. The lesions are isodense on all other phases. This case demonstrates the importance of arterial phase imaging in renal cell carcinoma follow-up. Noncontrast is noncontributory.

Hepatic Metastasis

 

Contralateral Kidney Metastases

59 year old man status post left nephrectomy for renal cell carcinoma with clear cell and papillary features in remission who developed metastatic disease in the contralateral kidney. Multiple enlarging masses(circles) in the right kidney showed little difference in attenuation between corticomedullary and nephrographic or nephrographic and delayed acquisitions. Comparison across > 2 phases is required for high diagnostic confidence regarding whether the new lesion is a complex cyst or solid mass. Either precontrast or delayed should be performed in addition to corticomedullary and nephrographic.

Hepatic Metastasis

 

References

  1. Chen F, Huhdanpaa H, Desai B, Hwang D, Cen S, Sherrod A, Bernhard JC, Desai M, Gill I, Duddalwar V. Whole lesion quantitative CT evaluation of renal cell carcinoma: differentiation of clear cell from papillary renal cell carcinoma. Springerplus. 2015 Feb 10;4:66.
  2. Renal Cell Carcinoma: Diagnosis, Staging, and Surveillance. Chaan S. Ng, Christopher G. Wood, Paul M. Silverman, Nizar M. Tannir, Pheroze Tamboli, and Carl M. Sandler. American Journal of Roentgenology 2008 191:4, 1220-1232
  3. Zhu YH, Wang X, Zhang J, Chen YH, Kong W, Huang YR. Low enhancement on multiphase contrast-enhanced CT images: an independent predictor of the presence of high tumor grade of clear cell renal cell carcinoma. AJR Am J Roentgenol. 2014 Sep;203(3):W295-300.
  4. Low, G., et al. (2016). "Review of renal cell carcinoma and its common subtypes in radiology." World Journal of Radiology 8(5): 484-500.
  5. Patel, H. D., et al. (2016). "Diagnostic Accuracy and Risks of Biopsy in the Diagnosis of a Renal Mass Suspicious for Localized Renal Cell Carcinoma: Systematic Review of the Literature." The Journal of Urology 195(5): 1340-1347.

 

References

  1. Gakis, G., et al. (2011). "Small renal Oncocytomas: Differentiation with multiphase CT." European Journal of Radiology 80(2): 274-278.
  2. Song, C., et al. (2009). "Differential Diagnosis of Complex Cystic Renal Mass Using Multiphase Computerized Tomography." The Journal of Urology 181(6): 2446-2450.
  3. Kim, S. H., et al. (2015). "Differentiation of Clear Cell Renal Cell Carcinoma From Other Subtypes and Fat-Poor Angiomyolipoma by Use of Quantitative Enhancement Measurement During Three-Phase MDCT." American Journal of Roentgenology 206(1): W21-W28.
  4. Kopp, R. P., et al. (2013). "Differentiation of clear from non-clear cell renal cell carcinoma using CT washout formula." Can J Urol 20(3): 6790-6797.
  5. Sureka, B., et al. (2014). "Dynamic computed tomography and Doppler findings in different subtypes of renal cell carcinoma with their histopathological correlation." Journal of Cancer Research and Therapeutics 10(3): 552-557.
  6. Raman, S. P., et al. (2013). "Chromophobe Renal Cell Carcinoma: Multiphase MDCT Enhancement Patterns and Morphologic Features." American Journal of Roentgenology 201(6): 1268-1276.

 

References

  1. Young, J. R., et al. (2013). "Clear Cell Renal Cell Carcinoma: Discrimination from Other Renal Cell Carcinoma Subtypes and Oncocytoma at Multiphasic Multidetector CT." Radiology 267(2): 444-453.
  2. Kim, J. K., et al. (2004). "Angiomyolipoma with Minimal Fat: Differentiation from Renal Cell Carcinoma at Biphasic Helical CT." Radiology 230(3): 677-684.
  3. Karlo, C. A., et al. (2013). "CT of Renal Cell Carcinoma: Assessment of Collecting System Invasion." American Journal of Roentgenology 201(6): W821-W827.
  4. Coquia, S. F., et al. (2013). "MDCT imaging following nephrectomy for renal cell carcinoma: Protocol optimization and patterns of tumor recurrence." World Journal of Radiology 5(11): 436-445.
  5. E.K. Lang, R. T., R. Davis, B. Shore, G. Ruiz-Deya, R.J. Macchia, B. Gayle, R.A. Watson, and F. Richter. Journal of Endourology. July 2004, 18(2): 167-171.
  6. Jain, Y., et al. (2011). "Is dual-phase abdominal CT necessary for the optimal detection of metastases from renal cell carcinoma?" Clinical Radiology 66(11): 1055-1059.
  7. Vincenzi, M., et al. (2014). "Imaging of pancreatic metastases from renal cell carcinoma." Cancer Imaging 14(1): 5-5.

 

References

  1. Wiklund F, Tretli S, Choueiri TK, Signoretti S, Fall K, Adami HO. Risk of bilateral renal cell cancer. J Clin Oncol. 2009 Aug 10;27(23):3737-41.
  2. Sirous, R., et al. (2016). "Metastatic renal cell carcinoma imaging evaluation in the era of anti-angiogenic therapies." Abdominal Radiology 41(6): 1086-1099.
  3. Thian, Y., et al. (2014). "Revised Choi Imaging Criteria Correlate with Clinical Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib." Radiology 273(2): 452-461.
  4. Johnson PT, Mahesh M, Fishman EK. Image Wisely and Choosing Wisely: Importance of Adult Body CT Protocol Design for Patient Safety, Exam Quality and Diagnostic Efficacy. JACR 2015 ; 12: 1185-1190
  5. Mettler FA, Huda W, Yoshizumi TT, Mahesh M. Effective doses in radiology and nuclear medicine: a catalog. Radiology 2008;248:254-63.

Privacy Policy

Copyright © 2024 The Johns Hopkins University, The Johns Hopkins Hospital, and The Johns Hopkins Health System Corporation. All rights reserved.